July 26, 2017
Oncolytics Biotech announced two abstracts describing both pooled safety and tolerability data and the mechanism of REOLYSIN will be presented...
December 19, 2016
Loxo Oncology today announced a comprehensive program update for larotrectinib (LOXO-101), a selective inhibitor of tropomyosin receptor kinase (TRK), and...
December 9, 2016
Novartis announced today additional analyses from the Phase III MONALEESA-2 study that show LEE011 (ribociclib) plus letrozole significantly prolonged progression-free...
November 13, 2016
Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.
November 7, 2016
Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter and nine months ended September 30, 2016.
November 6, 2016
Last week's top gainer was AveXis, Inc. followed by Heska Corp., Corcept Therapeutics, Atara Biotherapeutics and Seattle Genetics Inc.
October 30, 2016
Last week's top gainer was Alexion Pharmaceuticals, followed by LeMaitre Vascular, NeoGenomics Inc, United Therapeutics Corp. and Mesa Laboratories.